Ginsenosides Rg3 and Rh2 exhibit a potent cytotoxicity effect on the human hepatoma cell line, HepG2, by stimulating p53-mediated cell cycle arrest at the G1 to S phase transition, leading to apoptosis through the caspase signaling pathway [87]. This evidence concerns the gene TP53 and hepatocellular carcinoma.